Eloxx Pharmaceuticals Pink Sheet Forward View
| ELOX Stock | USD 0.0001 0.00 0.00% |
Eloxx Pink Sheet outlook is based on your current time horizon.
At this time the relative strength index (rsi) of Eloxx Pharmaceuticals' share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Eloxx Pharmaceuticals hype-based prediction, you can estimate the value of Eloxx Pharmaceuticals from the perspective of Eloxx Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Eloxx Pharmaceuticals on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Eloxx Pharmaceuticals after-hype prediction price | USD 1.0E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Eloxx |
Eloxx Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Eloxx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Eloxx using various technical indicators. When you analyze Eloxx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Eloxx Pharmaceuticals Naive Prediction Price Forecast For the 21st of February
Given 90 days horizon, the Naive Prediction forecasted value of Eloxx Pharmaceuticals on the next trading day is expected to be 0.0001 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Eloxx Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Eloxx Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Eloxx Pharmaceuticals Pink Sheet Forecast Pattern
| Backtest Eloxx Pharmaceuticals | Eloxx Pharmaceuticals Price Prediction | Research Analysis |
Eloxx Pharmaceuticals Forecasted Value
In the context of forecasting Eloxx Pharmaceuticals' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Eloxx Pharmaceuticals' downside and upside margins for the forecasting period are 0.0001 and 0.0001, respectively. We have considered Eloxx Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Eloxx Pharmaceuticals pink sheet data series using in forecasting. Note that when a statistical model is used to represent Eloxx Pharmaceuticals pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 30.385 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Eloxx Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eloxx Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Eloxx Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Eloxx Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Eloxx Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Eloxx Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Eloxx Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Eloxx Pharmaceuticals' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Eloxx Pharmaceuticals' historical news coverage. Eloxx Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.00 and 0.00, respectively. We have considered Eloxx Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Eloxx Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Eloxx Pharmaceuticals is based on 3 months time horizon.
Eloxx Pharmaceuticals Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Eloxx Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Eloxx Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Eloxx Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In a few days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.0001 | 0.0001 | 0.00 |
|
Eloxx Pharmaceuticals Hype Timeline
Eloxx Pharmaceuticals is currently traded for 0.0001. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Eloxx is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Eloxx Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.00. About 37.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 12.93. Eloxx Pharmaceuticals last dividend was issued on the 20th of December 2017. The entity had 1:40 split on the 2nd of December 2022. Given the investment horizon of 90 days the next estimated press release will be in a few days. Check out Historical Fundamental Analysis of Eloxx Pharmaceuticals to cross-verify your projections.Eloxx Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Eloxx Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Eloxx Pharmaceuticals' future price movements. Getting to know how Eloxx Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Eloxx Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NBRVF | Nabriva Therapeutics Plc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NEXI | Neximmune | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 100.00 | |
| MDVLQ | MedAvail Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| OMDD | Ormand Industries | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VRCI | Verde Science | 0.00 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CDXI | Cardax Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BIOCQ | Biocept | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 1,995 | |
| MICRD | Micron Solutions | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| NMSCA | Nutrition Management Services | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HTGMQ | HTG Molecular Diagnostics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Eloxx Pharmaceuticals
For every potential investor in Eloxx, whether a beginner or expert, Eloxx Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Eloxx Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Eloxx. Basic forecasting techniques help filter out the noise by identifying Eloxx Pharmaceuticals' price trends.Eloxx Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eloxx Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Eloxx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eloxx Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Eloxx Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Eloxx Pharmaceuticals pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Eloxx Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Eloxx Pharmaceuticals pink sheet market strength indicators, traders can identify Eloxx Pharmaceuticals entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Story Coverage note for Eloxx Pharmaceuticals
The number of cover stories for Eloxx Pharmaceuticals depends on current market conditions and Eloxx Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Eloxx Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Eloxx Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Eloxx Pharmaceuticals Short Properties
Eloxx Pharmaceuticals' future price predictability will typically decrease when Eloxx Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Eloxx Pharmaceuticals often depends not only on the future outlook of the potential Eloxx Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eloxx Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.2 M | |
| Cash And Short Term Investments | 19.2 M |
Additional Tools for Eloxx Pink Sheet Analysis
When running Eloxx Pharmaceuticals' price analysis, check to measure Eloxx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eloxx Pharmaceuticals is operating at the current time. Most of Eloxx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Eloxx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eloxx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Eloxx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.